Emiko Okuda-Ashitaka Selected Research

4-Nitrophenylphosphatase

1/2016

Involvement of NIPSNAP1, a neuropeptide nocistatin-interacting protein, in inflammatory pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emiko Okuda-Ashitaka Research Topics

Disease

14	Pain (Aches) 01/2020 - 10/2002
11	Hyperalgesia 01/2020 - 10/2002
7	Neuralgia (Stump Neuralgia) 02/2011 - 04/2003
3	Gyrate Atrophy 03/2011 - 01/2007
2	Inflammation (Inflammations) 01/2016 - 06/2008
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 01/2020
1	Joint Instability (Joint Laxity) 01/2020
1	Peripheral Nerve Injuries 02/2011
1	Pheochromocytoma 06/2008
1	Endotoxemia 06/2007
1	Neoplasms (Cancer) 06/2007
1	Nerve Degeneration 11/2006

Drug/Important Bio-Agent (IBA)

7	NociceptinIBA 01/2018 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2008
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 04/2003
4	NeuropeptidesIBA 01/2018 - 02/2006
4	nocistatinIBA 01/2018 - 03/2012
3	Dinoprostone (PGE2)FDA Link 01/2016 - 12/2005
3	OrnithineIBA 03/2011 - 01/2007
3	Transaminases (Aminotransferases)IBA 03/2011 - 01/2007
3	Retinal Pigments (Pigments, Visual)IBA 03/2011 - 01/2007
3	Nitric Oxide Synthase (NO Synthase)IBA 02/2011 - 12/2005
3	N-Methylaspartate (NMDA)IBA 02/2011 - 08/2004
3	Indomethacin (Indometacin)FDA LinkGeneric 02/2011 - 02/2006
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2010 - 08/2004
3	ProstaglandinsIBA 06/2008 - 12/2005
3	N- (4- amino- 2- methylquinolin- 6- yl)- 2- (4- ethylphenoxymethyl)benzamideIBA 02/2006 - 10/2002
2	Formaldehyde (Formol)FDA Link 01/2020 - 10/2002
2	Opioid Peptides (Opioid Peptide)IBA 01/2018 - 02/2006
2	Freund's AdjuvantIBA 01/2016 - 06/2008
2	CarrageenanIBA 01/2016 - 08/2004
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2011
2	Prostaglandins EIBA 02/2011 - 02/2006
2	Pharmaceutical PreparationsIBA 02/2011 - 02/2006
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 06/2008 - 08/2004
2	Nociceptin ReceptorIBA 02/2006 - 10/2002
2	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 02/2006 - 12/2005
1	tenascin XIBA 01/2020
1	TenascinIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Biotin (Vitamin H)FDA Link 01/2018
1	Pertussis ToxinIBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016
1	Inositol (Myoinositol)IBA 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 01/2016
1	LigandsIBA 01/2016
1	4-NitrophenylphosphataseIBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016
1	JNK Mitogen-Activated Protein KinasesIBA 01/2016
1	Type C PhospholipasesIBA 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	CCR2 ReceptorsIBA 01/2016
1	pyrazolanthroneIBA 01/2016
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	Opioid Analgesics (Opioids)IBA 03/2012
1	ArginaseIBA 03/2011
1	ONO 8713IBA 02/2011
1	Prostaglandin-E SynthasesIBA 02/2011
1	Adenosine Triphosphate (ATP)IBA 02/2011
1	Phosphotransferases (Kinase)IBA 09/2010
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2010
1	Phenylalanine (L-Phenylalanine)FDA Link 09/2010
1	Glutamate Receptors (Glutamate Receptor)IBA 06/2008
1	AMPA Receptors (AMPA Receptor)IBA 06/2008
1	N-Ethylmaleimide-Sensitive Proteins (N-Ethylmaleimide-Sensitive Fusion Protein)IBA 06/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	InterleukinsIBA 06/2007
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 04/2007
1	Protein Isoforms (Isoforms)IBA 11/2006
1	Prostaglandins FIBA 02/2006
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 12/2005
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 04/2003
1	Analgesics (Analgesic Drugs)IBA 04/2003
1	Dihydrotachysterol (AT 10)IBA 10/2002
1	benzamideIBA 10/2002

Therapy/Procedure

3	Spinal Injections 03/2012 - 08/2004
1	Intraperitoneal Injections 04/2003
1	Oral Administration 04/2003
1	Subcutaneous Injections 10/2002